Serum Stabilized Naked Caspase-3 Sirna Protects Auto-Transplant Kidneys in a Porcine Model.

Chen Yang,Tingting Zhao,Zhao Zhi-hong,Yu-Qin Jia,Liang Li,Y. Zhang,Mi‐Kyung Song,Ruang Rong,Ming Xu,Michael L. Nicholson,Tao Zhu,Yang Bai
DOI: https://doi.org/10.1097/00007890-201407151-00064
2014-01-01
Transplantation
Abstract:The naked small interfering RNA (siRNA) of caspase-3, a key player in ischemia reperfusion injury, was effective in cold preserved and hemoreperfused kidneys, but not auto-transplant kidneys in our porcine models. Here, chemically modified serum stabilized caspase-3 siRNAs were further evaluated. The left kidney was retrieved and infused by University of Wisconsin solution with/without 0.3 mg caspase-3 or negative siRNA into the renal artery for 24-h cold storage (CS). After intravenous injection of 0.9 mg siRNA and the right nephrectomy, the left kidney was auto-transplanted for 2 weeks. The effectiveness of caspase-3 siRNA was confirmed by caspase-3 knockdown in the post-CS and/or post-transplant kidneys with reduced apoptosis and inflammation, while the functional caspase-3 siRNA in vivo was proved by detected caspase-3 mRNA degeneration intermediate. HMGB1 protein was also decreased in the post-transplanted kidneys; most correlated with renal IL-1β mRNA positively, serum IL-10 or IL-4 negatively. The minimal off-target effects of caspase-3 siRNA were revealed with favorable systemic responses. More importantly, renal function, associated with active caspase-3, HMGB1, apoptosis, inflammation and tubulointerstitial damage, was improved by caspase-3 siRNA. Taken together, the 2-week auto-transplant kidneys were protected by caspase-3 siRNA administrated locally and systemically, which provides invaluable evidence for future clinical trials.Figure: No Caption available.
What problem does this paper attempt to address?